Urology
 |
|
2 june 2020 17:57:15 |
| Axitinib as a third or further line of treatment in renal cancer: a single institution experience (BMC Urology) |
|
Tweet Kidney cancer is a lethal neoplasm that affects several thousands of people every year. Renal cell carcinoma (RCC) is the most common histologic type. Recent developments in the therapeutic approach include an... |
| 327 viewsCategory: Urology |
 Can Biparametric Prostate Magnetic Resonance Imaging Fulfill its PROMIS? (European Urology)Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidence (BMC Urology) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page